Bristol-Myers Squibb and Celgene, a drug manufacturer specializing in treatments for cancer and inflammatory diseases, were hit with a patent infringement lawsuit Friday in New Jersey District Court. The lawsuit, which asserts one patent related to multiple sclerosis drug Zeposia, was filed by Robinson Miller LLC on behalf of Actelion Pharmaceuticals Ltd. Counsel have not yet appeared for the defendants. The case is 3:21-cv-18695, Actelion Pharmaceuticals Ltd. et al. v. Bristol-Myers Squibb Co. et al.
This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector.
